Nuveen’s Acer Therapeutics Inc ACER Stock Holding History

Nuveen’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,452	Closed	-$33K	–	3276
2019 Q3	$33K	Buy	+10,452	New	+$30.6K	﹤0.01%	3196

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nuveen's ACER Position: Q4 2019 in Review

Nuveen sold out of Acer Therapeutics Inc (ACER) in Q4 2019, closing a stake of 10,452 shares — an estimated $33K sold.

Nuveen first reported a position in ACER in Q3 2019 and held it in 1 quarter. The position peaked at $33K in Q3 2019. 40 funds tracked by Wall St. Rank hold ACER as of Q4 2019.

Nuveen reported no remaining Acer Therapeutics Inc position as of Q4 2019 after selling out during the quarter.
Nuveen sold 10,452 Acer Therapeutics Inc shares in Q4 2019, an estimated $33K.
Nuveen first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 1 quarter.
Nuveen's Acer Therapeutics Inc position peaked at $33K in Q3 2019.
40 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2019.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.